These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6386048)

  • 21. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
    Burke GT; Schwartz G; Katsoyannis PG
    Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions.
    Mirmira RG; Tager HS
    Biochemistry; 1991 Aug; 30(33):8222-9. PubMed ID: 1868095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
    Cara JF; Nakagawa SH; Tager HS
    Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
    Záková L; Barth T; Jirácek J; Barthová J; Zórad S
    Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of allo-Ile(A2)-insulin, an inactive chiral analogue: implications for the mechanism of receptor binding.
    Wan ZL; Xu B; Chu YC; Katsoyannis PG; Weiss MA
    Biochemistry; 2003 Nov; 42(44):12770-83. PubMed ID: 14596591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The biological properties of insulins with tyrosine replaced by phenylalanine at positions 14 and 19 of the A chain.
    Cockram CS; Jones RH; Sönksen PH
    Diabet Med; 1985 Jul; 2(4):241-4. PubMed ID: 2951075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro evolution of amphioxus insulin-like peptide to mammalian insulin.
    Guo ZY; Shen L; Gu W; Wu AZ; Ma JG; Feng YM
    Biochemistry; 2002 Aug; 41(34):10603-7. PubMed ID: 12186544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-function studies of analogues of parathyroid hormone (PTH)-1-34 containing beta-amino acid residues in positions 11-13.
    Peggion E; Mammi S; Schievano E; Silvestri L; Schiebler L; Bisello A; Rosenblatt M; Chorev M
    Biochemistry; 2002 Jun; 41(25):8162-75. PubMed ID: 12069609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (N-methylpyridinium)insulins. Modification at the A19- and B16-tyrosines.
    Drewes SE; Magojo HE; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1983 Apr; 364(4):461-8. PubMed ID: 6345335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photoaffinity labeling of insulin receptor with an insulin analogue selectively modified at the amino terminal of the B chain.
    Yeung CW; Moule ML; Yip CC
    Biochemistry; 1980 May; 19(10):2196-203. PubMed ID: 6990974
    [No Abstract]   [Full Text] [Related]  

  • 31. Steric requirements at position B12 for high biological activity in insulin.
    Hu SQ; Burke GT; Schwartz GP; Ferderigos N; Ross JB; Katsoyannis PG
    Biochemistry; 1993 Mar; 32(10):2631-5. PubMed ID: 8448120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Insulin analogues with substitution of A1-glycine by D-amino acids and omega-amino acids (author's transl)].
    Geiger R; Geisen K; Regitz G; Summ HD; Langner D
    Hoppe Seylers Z Physiol Chem; 1980 Apr; 361(4):563-70. PubMed ID: 6991387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification, characterization, and biological activity of insulins from the spotted dogfish, Scyliorhinus canicula, and the hammerhead shark, Sphyrna lewini.
    Anderson WG; Ali MF; Einarsdóttir IE; Schäffer L; Hazon N; Conlon JM
    Gen Comp Endocrinol; 2002 Mar; 126(1):113-22. PubMed ID: 11944972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Importance of the solvent-exposed residues of the insulin B chain alpha-helix for receptor binding.
    Glendorf T; Sørensen AR; Nishimura E; Pettersson I; Kjeldsen T
    Biochemistry; 2008 Apr; 47(16):4743-51. PubMed ID: 18376848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-standard insulin design: structure-activity relationships at the periphery of the insulin receptor.
    Weiss MA; Wan Z; Zhao M; Chu YC; Nakagawa SH; Burke GT; Jia W; Hellmich R; Katsoyannis PG
    J Mol Biol; 2002 Jan; 315(2):103-11. PubMed ID: 11779231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristic, activity and conformational studies of [A6-Ser, A11-Ser]-insulin.
    Dai Y; Tang JG
    Biochim Biophys Acta; 1996 Aug; 1296(1):63-8. PubMed ID: 8765230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superactive insulins.
    Burke GT; Hu SQ; Ohta N; Schwartz GP; Zong L; Katsoyannis PG
    Biochem Biophys Res Commun; 1990 Dec; 173(3):982-7. PubMed ID: 2268358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.
    Wan ZL; Huang K; Xu B; Hu SQ; Wang S; Chu YC; Katsoyannis PG; Weiss MA
    Biochemistry; 2005 Apr; 44(13):5000-16. PubMed ID: 15794638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semisynthesis and biological properties of the [B24-leucine]-, [B25-leucine[- and [B24-leucine, B25-leucine]-analogues of human insulin.
    Inouye K; Watanabe K; Tochino Y; Kanaya T; Kobayashi M; Shigeta Y
    Experientia; 1981; 37(8):811-3. PubMed ID: 7026270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.